Strantel Plus*2cpr

NAME
STRANTEL PLUS

PHARMACOTHERAPEUTIC CATEGORY
Anthelmintics. Associations.

ACTIVE PRINCIPLES
Each tablet contains: praziquantel 50 mg, pyrantel 50 mg (equivalent to 144 mg of pyrantel embonate), febantel 150 mg.

EXCIPIENTS
Lactose monohydrate, microcrystalline cellulose, magnesium stearate, anhydrous colloidal silica, croscarmellose sodium, sodium lauryl sulfate, pork flavor.

INDICATIONS
Treatment of mixed infections caused by roundworms and tapeworms of the following species. NEMATODE. Ascarids: Toxocara canis, Toxascaris leonina (adult and immature forms). Hookworms: Uncinaria stenocephala, Ancylostoma caninum (adults). Whipworms: Trichuris vulpis (adults). CESOTDI. Tapeworms: Echinococcus spp., (E. granulosus, E. multilocularis), Taenia spp. (T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum (adult and immature forms).

CONTRAINDICATIONS / SECONDARY EFFECT
Do not administer simultaneously with piperazine compounds. Do not administer to animals with known hypersensitivity to the active substances or to any of the excipients.

USE / ROUTE OF ADMINISTRATION
Oral.

DOSAGE
Administer orally only. For the dosages follow the indications below: 15mg / kg body weight for febantel, 5 mg / kg for pyrantel (equivalent to 14.4 mg of pyrantel embonate) and 5 mg / kg for praziquantel. Equivalent to 1 Strantel Plus tablet per 10kg of body weight. The tablets can be given directly to the dog or hidden in food. A period of fasting is not necessary, neither before nor after the treatment. If there is a risk of re-infestation, contact a veterinarian to ask for information on the need and frequency of other administrations.

STORAGE
This veterinary medicinal product does not require any special storage conditions. Discard unused tablets.

WARNINGS
Fleas are the intermediate hosts of a common type of tapeworm called Dipylidium caninum. Tapeworm infestation will certainly recur if control measures are not implemented on intermediate hosts, such as fleas, mice, etc. Tapeworm infestation is unlikely in puppies less than 6 weeks of age. Resistance of a parasite to a particular class of anthelmintics can develop following frequent, repeated use of an anthelmintic of that class. To ensure the correct dosage, body weight must be determined as accurately as possible. Special precautions to be taken by administering the product to animals: in case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician. In compliance with hygiene rules, wash your hands after administering the tablets directly to the dog or after adding them to his food. Overdose: The combined administration of praziquantel, pyrantel embonate and febantel is well tolerated by dogs. In safety studies, dosages five or more times the recommended dose occasionally induced vomiting.

WAITING TIME
Not relevant.

TARGET SPECIES
Dogs.

INTERACTIONS
Do not administer simultaneously with piperazine compounds as the anthelmintic effects of pyrantel and piperazine can be antagonized. Concomitant use of other cholinergic compounds may cause toxicity.

SIDE EFFECTS
None known.

PREGNANCY AND BREASTFEEDING
Teratogenic effects attributed to high doses of febantel have been reported in sheep and mice. No studies have been performed in bitches during the early part of pregnancy. The use of the product during pregnancy must be subject to an assessment of the risk / benefit ratio. It is recommended not to use the product in bitches during the first 4 weeks of pregnancy. Do not exceed the recommended dose when treating pregnant bitches.